What is the step‑by‑step management for a patient who is seizing?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 12, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Step-by-Step Management of a Seizing Patient

Administer a benzodiazepine immediately as first-line therapy, followed by a second-line antiepileptic agent (valproate, levetiracetam, or phenytoin/fosphenytoin) if seizures persist beyond 5 minutes or after optimal benzodiazepine dosing.

Initial Management (0-5 Minutes)

Immediate Actions

  • Position the patient safely to prevent injury during convulsive activity
  • Protect the airway without forcing objects into the mouth
  • Administer oxygen via non-rebreather mask or nasal cannula
  • Establish IV access immediately
  • Check fingerstick glucose and correct hypoglycemia if present

First-Line Treatment: Benzodiazepines

Benzodiazepines remain the cornerstone of initial seizure management with high certainty of evidence 1. Administer one of the following:

  • Lorazepam 4 mg IV (preferred due to longer duration of action)
  • Diazepam 10 mg IV
  • Midazolam 10 mg IM (if IV access unavailable)

Critical timing: If the seizure continues beyond 5 minutes or the patient has not returned to baseline, this defines status epilepticus and requires immediate escalation 2, 1.

Second-Line Management (5-20 Minutes)

If Seizures Persist After Benzodiazepines

You must administer an additional antiepileptic medication 3. The evidence shows comparable efficacy (50-60%) among second-line agents with no clear superiority 1. Choose based on the clinical scenario:

Option 1: Valproate 30 mg/kg IV (infused at 40 mg/min)

  • Advantages: 79% efficacy as second-line agent, no hypotension risk 3
  • Avoid in: Pregnancy, known liver disease, mitochondrial disorders
  • Class II evidence shows superior efficacy over phenytoin (79% vs 25%) 3

Option 2: Levetiracetam 30 mg/kg IV (maximum 3000 mg, infused at 5 mg/kg/min)

  • Advantages: Minimal drug interactions, no hypotension, efficacy 44-73% 3
  • Neutral profile: Safe in pregnancy, liver disease, elderly
  • Growing evidence base though mostly Class III studies 3

Option 3: Phenytoin 18-20 mg/kg IV or Fosphenytoin 20 PE/kg IV

  • Disadvantages: Only 56% efficacy, 12% hypotension risk, requires cardiac monitoring 3
  • Use when: Other agents contraindicated or unavailable
  • Historically standard but falling out of favor due to adverse effect profile 3

Simultaneous actions during infusion:

  • Search for reversible causes: Check sodium, assess for CNS infection, drug toxicity, stroke, intracranial hemorrhage, alcohol withdrawal 3
  • Prepare for potential intubation if seizures continue

Third-Line Management (20+ Minutes): Refractory Status Epilepticus

If Seizures Continue After Second-Line Agent

Prepare for anesthetic agents and ICU-level care 3. Options include:

Propofol 2 mg/kg bolus, then 5 mg/kg/hr infusion

  • Requires intubation and mechanical ventilation
  • Fewer ventilator days compared to pentobarbital (4 vs 14 days) 3
  • Less hypotension than barbiturates (42% vs 77%) 3

Phenobarbital 15-20 mg/kg IV

  • 58% efficacy as initial medication in Class I trial 3
  • Major limitation: High risk of respiratory depression and hypotension
  • Requires airway management preparation

Midazolam infusion (anesthetic doses)

  • Recommended by European Federation of Neurological Societies 3
  • Requires continuous EEG monitoring when available

Critical Pitfalls to Avoid

  1. Delayed treatment: The longer seizures continue, the harder they are to stop and the greater the risk of permanent neuronal damage 4

  2. Underdosing benzodiazepines: Ensure "optimal dosing" before declaring benzodiazepine failure 3

  3. Waiting for drug levels: Do not delay treatment waiting for antiepileptic drug levels 2

  4. Ignoring reversible causes: Always check glucose immediately; assess for hyponatremia, hypoxia, and infection 3

  5. Inadequate airway preparation: Patients in refractory status epilepticus frequently require advanced airway management 4

Special Considerations

For known epilepsy patients: The evidence does not support one route (oral vs IV) over another for resuming home medications in preventing early recurrent seizures 3. However, in the acute seizing patient, IV access is mandatory for emergency treatment.

Nonconvulsive status epilepticus: Patients who remain altered after apparent seizure cessation may have ongoing subclinical seizures requiring EEG monitoring 2.

The ESETT trial demonstrated no superiority among second-line antiseizure drugs 1, allowing you to individualize based on patient-specific contraindications rather than efficacy differences.

References

1
Research

Management of status epilepticus in the emergency department: Systematic review and clinical update.

Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias, 2026

Related Questions

In a patient with known epilepsy who had a seizure three days ago and has normal vital signs, what is the appropriate next management?
What are the recommended dosing regimens for acute seizure treatment in an adult, including first‑line benzodiazepine and second‑line antiseizure medications?
Should chest compressions be initiated on a patient who is actively having a seizure?
What is the appropriate emergency management for a patient experiencing an acute epileptic seizure, including safety measures, medication dosing, and follow‑up?
What is the management of an acute seizure at a nursing home?
What is the correct dosing schedule for Invega (paliperidone palmitate) and how should I manage persistent hallucinations, crying, and sadness while on a 156 mg dose?
Should I refill benzonatate and Bromfed (brompheniramine) for a patient who has not reported a cough in over a year?
Which antipsychotic has the lowest risk of white‑blood‑cell changes for an adult with cirrhosis requiring acute control of agitation or psychotic symptoms?
What acid‑base disorder does a chronically ventilated patient have with an anion gap of 16, serum bicarbonate of 19 mEq/L, pH 7.47, and pCO₂ of 27 mm Hg?
What medication should be prescribed for toenail onychomycosis in a patient with an estimated glomerular filtration rate of 50 mL/min?
What is the recommended long-term maintenance therapy for bipolar disorder in an adult patient with cirrhosis?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.